Prepare for global data class actions has been moved. In the wake of the COVID-19 epidemic, there is an unfortunate increase in the cyber-security risks businesses may face. Our global team will help you best prepare for the...more
4/8/2020
/ Class Action ,
Collective Actions ,
Collective Redress ,
Compliance ,
Coronavirus/COVID-19 ,
Cross-Border ,
Cybersecurity ,
Data Breach ,
Data Privacy ,
EU ,
General Data Protection Regulation (GDPR) ,
Member State ,
Mexico ,
Regulatory Oversight ,
Risk Management ,
Russia ,
United States ,
Webinars
Once again there is a new attempt in Germany to introduce stricter requirements for food safety – despite the full harmonization approach in general EU food law...more
2/26/2020
/ EU ,
Food Contamination ,
Food Manufacturers ,
Food Safety ,
Food Supply ,
Germany ,
Harmonization Rules ,
Public Health ,
Regulatory Oversight ,
Regulatory Requirements ,
Transparency
It's been a year since the European Commission published its Fifth Report on the application of the European Product Liability Directive (the "Directive") and set up expert panels to develop its thinking on next policy steps....more
6/4/2019
/ Algorithmic Trading ,
Artificial Intelligence ,
Blockchain ,
Connected Items ,
Disruptive Technology ,
Driverless Cars ,
EU ,
EU Directive ,
European Commission ,
Regulatory Oversight ,
Regulatory Standards ,
Strict Liability
At the next Annual General Meeting of the German Medical Association (Deutscher Ärztetag), the current restrictions on remote treatment by German physicians will most likely be overturned....more
Innovation in the life sciences and health care industries is occurring at a dizzying pace. Five years ago, anti-PD-1 antibodies from Merck and BMS had yet to be approved, CAR-T therapies were still in small-scale clinical...more
4/4/2018
/ 3D Printing ,
Acquisitions ,
Artificial Intelligence ,
Biologics ,
Biosimilars ,
Biotechnology ,
Blockchain ,
Cyber Attacks ,
Cybersecurity ,
Data Breach ,
Digital Health ,
Distributed Ledger Technology (DLT) ,
Drug Pricing ,
Emerging Markets ,
EU ,
General Data Protection Regulation (GDPR) ,
Generic Drugs ,
Innovation ,
Life Sciences ,
Medical Reimbursement ,
Mergers ,
Over The Counter Derivatives (OTC) ,
Pharmaceutical Industry ,
Prescription Drugs ,
Private Equity ,
Regulatory Oversight ,
Supply Chain ,
Transfer Pricing ,
UK Brexit ,
Yates Memorandum